[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363931-105":59,"doc-detail-363931-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","atf4-zik1-and-pnma3-transcriptomic-signatures-predict-chemoradiotherapy-response-in-cervical-cancer","ATF4, ZIK1, and PNMA3 Transcriptomic Signatures Predict Chemoradiotherapy Response in Cervical Cancer","","Cervical cancer remains a major malignancy with substantial global mortality, and chemoradiotherapy resistance limits treatment success. This open-access study aimed to identify gene expression signatures that can indicate treatment response in cervical cancer patients. Non-stem cell samples from responders and non-responders underwent next-generation RNA sequencing, followed by differential expression and machine-learning analyses to select clinically relevant genes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/atf4-zik1-and-pnma3-transcriptomic-signatures-predict-chemoradiotherapy-response-in-cervical-cancer/363931/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/atf4-zik1-and-pnma3-transcriptomic-signatures-predict-chemoradiotherapy-response-in-cervical-cancer/363931.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary goal of the study?","Question",{"text":112,"@type":113},"To identify transcriptomic gene-expression signatures that could predict chemoradiotherapy response in cervical cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were responder and non-responder samples selected and analyzed?",{"text":117,"@type":113},"Non-stem cervical cancer cell samples were selected using fluorescence-activated cell sorting from responder and non-responder patients and analyzed by next-generation RNA sequencing, followed by differential expression and machine-learning/statistical analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genes were most strongly linked to non-response and responder status?",{"text":121,"@type":113},"PNMA3 and ZIK1 were markedly upregulated in non-responder patients, while ATF4 (and ATP1B3) were identified among genes upregulated in responder patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363931,1791078920,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>ATF4, ZIK1, and PNMA3 Transcriptomic Signatures Predict Chemoradiotherapy Response in Cervical Cancer\u003Cbr>Angelo Borges de Melo Neto1 | Fábio Ribeiro Queiroz2 | Carolina Pereira de Souza Melo2 |\u003Cbr>Bruna Custódio Dias Duarte1  | Jorge Gomes Goulart Ferreira2 | Izabela Ferreira Gontijo de Amorim2 | Laurence Rodrigues do Amaral1 | Pedro Luiz Lima Bertarini1 | Telma Maria Rossi de Figueiredo Franco2 |\u003Cbr>Andréa Teixeira de Carvalho3  | Olindo Assis Martins-Filho3 | Wander de Jesus Jeremias4 | Letícia da Conceição Braga2,5  Paulo Guilherme de Oliveira Salles2 | Matheus de Souza Gomes1\u003Cbr>1Laboratório de Bioinformática e Análises Moleculares, Universidade Federal de Uberlândia, Patos de Minas, Brazil | 2Laboratório de Pesquisa Básica e Translacional em Oncologia, Núcleo de Ensino, Pesquisa e Inovação, Instituto Mário Penna, Belo Horizonte, Brazil | 3Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Belo Horizonte, Brazil | 4Laboratório de Farmacologia Experimental, Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto, Brazil | 5Programa de Pós-graduação em Ciências Morfofuncionais, Universidade Federal de São João D'El Rei, São João D'El Rei, Brazil\u003Cbr>Correspondence: Matheus de Souza Gomes ([matheusgomes@ufu.br](matheusgomes@ufu.br))\u003Cbr>Received: 12 November 2025 | Revised: 22 May 2026 | Accepted: 12 June 2026\u003Cbr>Keywords: ATF4 | cervical cancer | chemoradiotherapy resistance | PNMA3 | ZIK1 |\n| --- |\n| ABSTRACT\u003Cbr>Background: Cervical cancer (CC) is a main malignancy affecting women globally, with a high mortality rate. Chemoradiotherapy resistance is a significant factor in determining treatment outcomes, and prognostic biomarkers are essential for the appropriate selection of therapeutic strategies. This study aimed to identify gene expression signatures that may allow for follow-up treatment response in CC patients.\u003Cbr>Methods: Samples of non-stem CC cells selected by Fluorescence-activated Cell Sorting from 21 Responders and 10 Nonresponder patients, who attended the Mario Penna Institute (Belo Horizonte—Brazil) from August 2017 to May 2018, and submitted to Next-generation RNA sequencing, were analyzed to evaluate differential gene expression profiles between both groups. Machine Learning and statistical analyses were performed to identify a signature related to clinical outcomes.\u003Cbr>Results: 2670 Differentially expressed genes (DEGs) with log2FoldChange ≤−1 or ≥ 1 and adjusted p-value ≤0.05 were found. Of these, 1591 were protein-coding, but only 8 were considered relevant based on machine-learning and statistical analyses for classifying treatment response. However, only PNMA3 and ZIK1 were markedly upregulated in non-responder patients. Among the genes upregulated in Responder patients, only ATF4 and ATP1B3 were identified by machine-learning analysis. On the other hand, only ATF4, PNMA3, and ZIK1 were associated in network interactions, more specifically to apoptosis pathways, and the differential expression of ATF4 and PNMA3 occurred exclusively in cervical cancer non-stem cells, in the presence of ZIK1. |\n|  |\n| Abbreviations: AC, adenocarcinoma; ATF, activating transcription factor family; CC, cervical cancer; CCNSCs, cervical cancer non-stem cells; CCSCs, cervical cancer stem-like cells; CESC, cervical squamous cell carcinoma; CI, confidence interval; CPR, cisplatin resistance; CR, complete response; DEGs, differentially expressed genes; DGE, differential gene expression; DT, decision tree; EMT, epithelial mesenchymal transition; FACS, fluorescence-activated cell sorting; H&E, hematoxylin and eosin; HPF, high-power fields; HR, hazard ratio; IG, information gain; iTIL, intra-tumoral tumor-infiltrating lymphocytes; Log2FC, Log2 fold change; LOOCV, leave-one-out cross-validation; MLE, maximum likelihood estimates; NR, non-responder; OS, overall survival; padj, adjusted p-value; PD, progressive disease; PNMA, paraneoplastic Ma family; ","cbCaibvKdVSFv4g4","https://ap.wps.com/l/cbCaibvKdVSFv4g4","pdf",4718639,23,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the primary goal of the study?\",\"answer\":\"To identify transcriptomic gene-expression signatures that could predict chemoradiotherapy response in cervical cancer patients.\"},{\"question\":\"How were responder and non-responder samples selected and analyzed?\",\"answer\":\"Non-stem cervical cancer cell samples were selected using fluorescence-activated cell sorting from responder and non-responder patients and analyzed by next-generation RNA sequencing, followed by differential expression and machine-learning/statistical analyses.\"},{\"question\":\"Which genes were most strongly linked to non-response and responder status?\",\"answer\":\"PNMA3 and ZIK1 were markedly upregulated in non-responder patients, while ATF4 (and ATP1B3) were identified among genes upregulated in responder patients.\"}]","ATF4, ZIK1, and PNMA3 Transcriptomic Signatures Predict Chemoradiotherapy Response in Cervical Cancer | PDF",1790154249,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2547b65fe6cfe8326c6c70fabb2c5134.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a268f0af2faf0cf2478d41d0040addf.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bcb663dd5ab9dd85e9ec6419488fbf7.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/110a608ca75605c2f6b31e14267f4214.webp",980,1287]